RPS6KA3 and ovarian cancer: RSK1 and RSK2 are associated with cell growth, survival, and proliferation [12,37], whereas RSK4 expression is reduced in ovarian cancer, colorectal cancer, acute myeloid leukemia, and breast cancer [18,37].